Revolution Medicines share price logo

Revolution Medicines

NASDAQ: RVMD

Large Cap

$214.66

-1.34

(-0.62%)

as on

Revolution Medicines Stock Performance

as on August 20, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $212.25
    $220.34
    downward going graph

    1.12%

    Downside

    2.65%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $35.42
    $208.76
    downward going graph

    83.50%

    Downside

    -2.75%

    Upside

    downward going graph

Revolution Medicines share price movements today

Previous Close
$216.00
Open
$218.49
Volume
693.0K
Market Cap
$43.7B
Day's Low - High
$212.25 - $220.34
52 Week Low - High
$35.42 - $208.76

Revolution Medicines Historical Returns

1 Month Return
+ 9.43 %
3 Month Return
+ 39.85 %
1 Year Return
+ 460.88 %
3 Year Return
+ 595.49 %
5 Year Return
+ 669.3 %

Revolution Medicines Stock Fundamentals & Key Indicators

Check Revolution Medicines market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$43.7B

EPS (TTM)

-9.5642

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-1.6B

Revenue (TTM)

742.0K

Profit Margin

0.00%

Return On Equity TTM

-79.09%

Revolution Medicines vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Revolution Medicines with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Revolution Medicines Stock including INR - Dollar returns

The Revolution Medicines stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Revolution Medicines investment value today

Current value as on today

₹6,49,896

Returns

₹5,49,896

(+549.9%)

Returns from Revolution Medicines Stock

₹4,91,024 (+491.02%)

Dollar Impact

₹58,872 (+58.87%)

Analyst Recommendation on Revolution Medicines Stock

Based on 19 analysts

BUY

94.74%

Buy

5.26%

Hold

0.00%

Sell

Based on 19 analysts, 94.73684210526315% of analysts recommend a 'BUY' rating for Revolution Medicines. Average target price of $221.9

Revolution Medicines Share Price Target

Get share price movements and forecasts by analysts on Revolution Medicines.

What analysts predicted

3.26%UPSIDE

Target Price

$221.9

Current Price

$214.66

Analyzed by

19 Analysts

Target

$221.90

Revolution Medicines target price $221.9, a slight upside of 3.26% compared to current price of $214.66. According to 19 analysts rating.

Indian Investors' Interest in Revolution Medicines Stock

Investment in Revolution Medicines Shares on INDmoney has dropped by -5.75% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-5.75% versus previous 30 day period

Revolution Medicines Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
261
-
-
-
-
-
-
Gross Profit
-118
-12
-151
-188
-205
-3
-
-4
-4
-
Operating Income
-140
-156
-175
-216
-240
-264
-315
-361
-445
-505
EBITDA
-113
-130
-153
-191
-209
-243
-289
-348
-437
-620
Interest Expense
-
-
-
-
-
0
11
11
12
23
Depreciation
2
2
2
3
3
3
4
4
4
9
Income Before Tax
-116
-133
-156
-195
-213
-247
-305
-364
-453
-644
Income Tax Expense
-2
-
-156
0
-
-
-
-
-
-
Net Income
-116
-133
-156
-194
-213
-247
-305
-364
-453
-644
Net Profit Margin
0.00%
0.00%
0.00%
-74.38%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Revolution Medicines Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
20
50
42
29
35
11
-
-
Gross Profit
-26
20
50
42
29
35
11
-592
-16
Operating Income
-31
-40
-54
-110
-188
-258
-487
-689
-1,182
EBITDA
-29
-39
-48
-101
-179
-239
-430
-589
-1,090
Interest Expense
0
0
0
0
0
9
0
-
24
Depreciation
1
1
3
6
7
9
9
11
16
Income Before Tax
-31
-41
-52
-108
-187
-249
-439
-600
-1,131
Income Tax Expense
0
-1
-4
0
-7
0
-3
0
-
Net Income
-31
-41
-47
-108
-187
-248
-436
-600
-1,131
Net Profit Margin
0.00%
-207.24%
-95.25%
-251.63%
-636.58%
-702.95%
-3768.28%
0.00%
0.00%

Revolution Medicines Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-133
-156
-194
-213
-247
-305
-364
-453
-1,098
Operating Cash Flow
-128
-130
-138
-194
-221
-207
-274
-354
-741
Investing Cash Flow
107
-21
-392
-15
34
24
74
172
-1,486
Financing Cash Flow
7
77
873
0
256
-1
365
238
2,659
Change in Cash
-12
-74
341
-209
69
-184
166
57
431

Revolution Medicines Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-47
-108
-187
-248
-436
-600
-1,131
Operating Cash Flow
1
-49
-100
-147
-224
-350
-557
-897
Investing Cash Flow
-1
-101
-234
-142
-24
-342
-554
118
Financing Cash Flow
60
98
422
294
301
1,229
959
621
Change in Cash
60
-52
88
4
52
534
-153
-158

Mutual Funds that own Revolution Medicines Stock

Check out the Mutual Funds with significant holdings in Revolution Medicines.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.896182%
14781030
JANUS INVESTMENT FUND
1.822351%
3905963
Fidelity Mt. Vernon Street Trust
1.782047%
3819576
VANGUARD SPECIALIZED FUNDS
0.857718%
1838404
Fidelity Concord Street Trust
0.848415%
1818464

Global Institutional Holdings in Revolution Medicines

Funds
Holdings
Vanguard
7.88%
Andrew J.M. Spokes
6.35%
Felix Baker
4.46%
iShares
3.46%
Xtrackers
1.39%

Revolution Medicines News & Key Events

  • img

    Today's Timeline - 31 May

    Mon, 08:13 AM

    -

    Revolution Medicines reports daraxonrasib doubles survival in pancreatic cancer trial, reducing death risk by 60%.

Insights on Revolution Medicines

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revolution Medicines, Inc. has shown strong revenue growth over the last two quarters. In the most recent quarter, revenue increased from $742,000 to $261.59 million, marking an average growth rate of 99.7% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RVMD stock has moved up by 42.8%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RVMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RVMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Revolution Medicines, Inc. has experienced a decline in net profit for the last 10 quarters. The net profit has decreased from -116.00 million dollars to -644.37 million dollars, resulting in an average quarterly decrease of 21.3%.

About Revolution Medicines

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
OrganisationRevolution Medicines
Headquarters700 Saginaw Drive, Redwood City, CA, United States, 94063
IndustryBiotechnology
CEODr. Mark A. Goldsmith M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Revolution Medicines

Name

Title

Dr. Mark A. Goldsmith M.D., Ph.D.

CEO, President & Chairman

Mr. Jack Anders

Chief Financial Officer

Ms. Margaret A. Horn J.D.

Chief Operating Officer

Mr. Jeffrey Cislini J.D.

Senior VP, General Counsel & Corporate Secretary

Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.

Senior Advisor

Dr. Martin D. Burke M.D., Ph.D.

Co-Founder & Chairman of Scientific Advisory Board

Dr. Kevan M. Shokat Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

Mr. Walter Reiher Ph.D.

Chief Information Officer

Ms. Jan Smith Ph.D.

Chief Scientific Officer

Dr. Michael A. Fischbach Ph.D.

Academic Co-Founder & Member of Scientific Advisory Board

FAQs

What is Revolution Medicines share price today?

Revolution Medicines share price today is $214.66 as on at the close of the market. Revolution Medicines share today touched a day high of $220.34 and a low of $212.25.

What is the 52 week high and 52 week low for Revolution Medicines share?

Revolution Medicines share touched a 52 week high of $208.76 on and a 52 week low of $35.42 on . Revolution Medicines stock price today i.e. is closed at $214.66,which is -2.83% down from its 52 week high and 506.04% up from its 52 week low.

What is Revolution Medicines's market capitalisation today?

Revolution Medicines market capitalisation is $0.04T as on .

How to invest in Revolution Medicines Stock (RVMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Revolution Medicines on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Revolution Medicines Shares that will get you 0.0070 shares as per Revolution Medicines share price of $214.66 per share as on August 20, 2026 at 8:45 am IST.

What is the minimum amount required to buy Revolution Medicines Stock (RVMD) from India?

Indian investors can start investing in Revolution Medicines (RVMD) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Revolution Medicines stock (as per the Rupee-Dollar exchange rate as on ). Based on Revolution Medicines share’s latest price of $214.66 as on August 20, 2026 at 8:45 am IST, you will get 0.0466 shares of Revolution Medicines. Learn more about fractional shares .

What are the returns that Revolution Medicines has given to Indian investors in the last 5 years?

Revolution Medicines stock has given 669.3% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?